Observation of the therapeutic effect of apatinib in advanced platinum-resistant recurrent epithelial ovarian cancer

• Main Authors: Zhongmian Pan (Author), Zhongbin Luo (Author), Hongying He (Author), Yujie Chen (Author), Bingbing Zhao (Author), Zhijun Yang (Author), Li Li (Author)
• Formato: Livro
• Publicado em: BMC, 2023-02-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Abstract Background Apatinib is an oral anti-angiogenic drug that mainly targets vascular endothelial growth factor receptor 2 (VEGFR-2) and is widely used in a variety of solid tumours. The purpose of this study is to evaluate the clinical efficacy and safety of apatinib in patients with advanced p...